Latest filing published 16 Apr 2013 for Fortress Biotech, Inc..
Insider track record
No signal scores available.
Closed purchases
Based on 3 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- -62.8%Entry US$66.90 · Close at T+365 US$24.90
- +5.9%Entry US$81.00 · Close at T+365 US$85.80
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Bobby W. Sandage PhD: trading record in brief
Bobby W. Sandage PhD has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Indevus Pharmaceuticals Inc and Fortress Biotech, Inc. We count 14 filings; the first trade dates from 25 January 2006 and the latest from 5 April 2013.
Purchases make up the whole of the open-market record (4 purchases, €58k). Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Besides market trades, the filings include 4 share grants and 2 option exercises.
In size, the median ticket on the buying side is €7,948. For 3 purchases whose 90-day window has closed, the share price was higher on day 90 than the day after publication in 100% of cases, with a median move of +57.2%. Past outcomes like these are no guarantee of what comes next.
On 16 April 2013 came the latest disclosure, a transaction in Fortress Biotech, Inc. The last purchase on record was published on 3 December 2012, which is 5,089 days ago. The median gap between a trade and its publication by SEC (Form 4) is 2 days. The legal deadline for a Form 4 is two business days after the transaction. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Bobby W. Sandage PhD
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 3,000 shares0Common Stock, par value $0.001SEC:0001181431-13-022348:0
- 3,811 shares@ US$4.02Common Stock, par value $0.001SEC:0001181431-12-061834:0Canonical exit: 28 Feb 2013 (T+90)
- 1,000 shares@ US$5.20Common Stock, par value $0.001SEC:0001209191-12-003499:0Canonical exit: 11 Apr 2012 (T+90)
- 500 shares@ US$5.28Common Stock, par value $0.001SEC:0001209191-12-003499:1Canonical exit: 10 Apr 2012 (T+90)
- 130,601 sharesCommon StockSEC:0001181431-09-011285:0
- 100,443 shares0Common StockSEC:0001181431-09-011285:1
- 100,443 sharesCommon StockSEC:0001181431-09-011285:2
- 55,918 shares0Common StockSEC:0001181431-08-054740:0
- 13,500 shares0Common StockSEC:0001181431-07-065475:0
- 870 shares@ US$2.37Common Stock, $.001 par valueSEC:0001181431-06-021995:0
- 28,800 shares0Common StockSEC:0001181431-06-017228:0
- 3,000 shares@ US$2.38Common Stock, $.001 par valueSEC:0001181431-06-006153:0
- 3,000 shares0Common Stock, $.001 par valueSEC:0001181431-06-006153:1
13 of 13 declarations